您也可能阅读
通过共同作者、期刊和引用图与本文相关的文章。
Sophia R O'Brien1, Christine E Edmonds2, Rebecca E Ward3
1Division of Nuclear Medicine Imaging and Therapy, Department of Radiology, Hospital of the University of Pennsylvania, Philadelphia, PA; Department of Radiology, Division of Breast Imaging, Hospital of the University of Pennsylvania, Philadelphia, PA.
18F-16α-Fluoroestradiol (18F-FES) PET/CT成像被批准用于ER+转移性乳腺癌. 它识别了可能对内分泌治疗有反应的患者,指导治疗决策并改善患者的治疗结果.
科学领域:
背景情况:
研究的目的:
主要方法:
主要成果:
结论: